Cargando…
Alterated gene expression in dilated cardiomyopathy after left ventricular assist device support by bioinformatics analysis
INTRODUCTION: Heart transplantation is the best treatment for end-stage dilated cardiomyopathy (DCM). Left ventricular assist device (LVAD) support is becoming more prevalent and may delay heart transplantation. Gene expression of the left ventricular myocardium usually changes following LVAD implan...
Autores principales: | Wei, Ying, Cao, Hao, Peng, Yuan-Yi, Zhang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063844/ https://www.ncbi.nlm.nih.gov/pubmed/37008310 http://dx.doi.org/10.3389/fcvm.2023.1013057 |
Ejemplares similares
-
Case report: Successful percutaneous extracorporeal magnetic levitation ventricular assist device support in a patient with left heart failure due to dilated cardiomyopathy
por: Li, Ping, et al.
Publicado: (2023) -
Left ventricular assist device bioinformatics identify possible hubgenes and regulatory networks involved in the myocardium of patients with left ventricular assist device
por: Ajmal, Maryam, et al.
Publicado: (2022) -
Changes in the Left Ventricular Eicosanoid Profile in Human Dilated Cardiomyopathy
por: Sosnowski, Deanna K., et al.
Publicado: (2022) -
Association Between Left Ventricular Global Function Index and Outcomes in Patients With Dilated Cardiomyopathy
por: Liu, Tong, et al.
Publicado: (2021) -
Radiomics-Based Classification of Left Ventricular Non-compaction, Hypertrophic Cardiomyopathy, and Dilated Cardiomyopathy in Cardiovascular Magnetic Resonance
por: Izquierdo, Cristian, et al.
Publicado: (2021)